Sanofi (SNY) Current Leases (2019 - 2026)

Sanofi has disclosed Current Leases across 8 years of filings, most recently posting $263.9 million for Q2 2026.

• In Q2 2026, Current Leases fell 7.5% year-over-year to $263.9 million; the TTM figure through Jun 2026 stood at $263.9 million (down 7.5% YoY), while the FY2025 annual figure was $316.6 million, up 12.08% from the prior year.
• Current Leases came in at $263.9 million for Q2 2026 at Sanofi, down from $316.6 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $316.6 million in Q4 2025 to a low of $246.5 million in Q2 2022.
• Average Current Leases over 5 years is $282.8 million, with a median of $282.6 million recorded in 2022.
• Year-over-year, Current Leases slipped 17.13% in 2022 and grew 13.52% in 2025.
• Over 5 years, Current Leases stood at $282.6 million in 2022, then advanced by 4.7% to $295.9 million in 2023, then retreated by 5.74% to $278.9 million in 2024, then climbed by 13.52% to $316.6 million in 2025, then dropped by 16.66% to $263.9 million in 2026.
• Per Business Quant data, the three most recent Current Leases figures were $263.9 million in Q2 2026, $316.6 million in Q4 2025, and $285.3 million in Q2 2025.